RL2
ACCDIS > RL2
13
Aug
Potential adverse cardiac remodelling in highly trained athletes: still unknown clinical significance. Eur J Sport Sci
Gabrielli L, Sitges M, Chiong M, Jalil J, Ocaranza M, Llevaneras S, Herrera S, Fernandez R, Saavedra R, Yañez F, Vergara L, Diaz A, Lavandero S, Castro P
13
Aug
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT2R and Akt-dependent mechanism Pharmacol Res.
Evelyn Mendoza Torresa, Jaime A. Riquelme, Alejandra Vielma, Andrea Ramirez Sagredo, Luigi Gabrielli, Roberto Bravo Sagua, Jorge E. Jalil, Beverly a.. Rothermel, Gina Sanchez, Maria Paz Ocaranza, Sergio Lavandero
13
Aug
Increased active phase atrial contraction is related to marathon runner performance European Journal of Applied Physiolog
Luigi Gabrielli, Sebastian Herrera, Felipe Contreras Briceño, Julian Vega, María Paz Ocaranza, Fernando Yanez, Rodrigo Fernandez, Rodrigo Saavedra, Marta Sitges, Lorena Garcia, Mario Chiong, Sergio Lavandero, Paul F. Castro
13
Aug
Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension. Biochem Pharmacol
Gonzalez L, Novoa U, Moya J, Gabrielli L, Jalil JE, García L, Chiong M, Lavandero S, Ocaranza MP.
13
Aug
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches. Theranostics.
Bejarano J, Navarro Marquez M, Morales Zavala F, Morales JO, Garcia Carvajal I, Araya Fuentes E, Flores Y, Verdejo HE, Castro PF, Lavandero S, Kogan MJ
13
Aug
Label-Free Graphene Oxide-Based Surface Plasmon Resonance Immunosensor for the Quantification of Galectin-3, a Novel Cardiac Biomarker ACS Appl Mater Interfaces
Primo EN, Kogan MJ, Verdejo HE, Bollo S, Rubianes MD, Rivas GA.